NCT02188628

Trial name or title	Refinement and clinical evaluation of the H‐Man: a novel, portable, inexpensive planar robot for arm rehabilitation after stroke
Methods	RCT
Participants	Country: Singapore Participants: estimated enrolment n = 60 Inclusion criteria: age between 21 and 85 years; first‐ever clinical stroke confirmed by imaging; time since stroke between 3 and 24 months; hemiplegic pattern of motor impairment with MRC motor power of shoulder and elbow flexion grade ≥ 3; FMA score of the affected upper limb between 20 and 50 points; motor inco‐ordination or motor ataxia Exclusion criteria: other causes of arm motor impairment; severe medical conditions; palliative care; severe arm pain; inability to sit for 90 minutes; local fractures; spasticity of MAS grades 3 to 4; skin wounds; shoulder pain > 5/10 visual analogue scale; severe sensory impairment of affected limb; severe visual impairment; hemispatial neglect or homonymous hemianopia; cognitive impairments or uncontrolled behaviour; Mini‐Mental State Examination < 26/28
Interventions	Experimental group: H‐Man (end‐effector upper limb robot; dosage not stated) Control group: additional conventional therapy (repetitive goals‐based arm therapy; dosage not stated)
Outcomes	Outcomes will be collected at baseline and at 3, 6, 12, and 24 weeks after start of the intervention Primary outcomes: FMA Secondary outcomes: ARAT
Starting date	July 2014
Contact information	Chua SG Sui Geok; karen_chua@ttsh.com.sg
Notes